Skip to Content
Merck
CN

F2427

Fluprostenol isopropyl ester

≥98%, ethanol solution

Synonym(s):

(±)-16-(m-Trifluoromethylphenoxy)tetranorprostaglandin F2, Travoprost

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C26H35F3O6
CAS Number:
157283-68-6
Molecular Weight:
500.55
NACRES:
NA.77
PubChem Substance ID:
329799691
UNSPSC Code:
12352200
EC Number:
200-578-6
MDL number:
MFCD03411995
Assay:
≥98%
Form:
ethanol solution
Quality level:
200

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Fluprostenol isopropyl ester, ≥98%, ethanol solution

InChI

1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1

InChI key

MKPLKVHSHYCHOC-AHTXBMBWSA-N

SMILES string

CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc2cccc(c2)C(F)(F)F

assay

≥98%

form

ethanol solution

shipped in

wet ice

storage temp.

−20°C

Quality Level

200

Gene Information

human ... PTGFR(5737)

Biochem/physiol Actions

Potent FP prostanoid receptor agonist used in animal models for glaucoma.

pictograms

FlameExclamation mark
GHS02,GHS07

signalword

Danger

hcodes

H225,H319

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2

Storage Class

3 - Flammable liquids

wgk

WGK 2

flash_point_f

62.6 °F - closed cup

flash_point_c

17 °C - closed cup

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
SLCN7743
SLCF6879
SLCD6917
SLBP1489V
SLBM6966V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Chengpu Zhang
Pakistan journal of pharmaceutical sciences, 28(2 Suppl), 781-784 (2015-03-23)
This study discussed about the influence of local application of glaucoma medications -- travoprost eye drops to patients' tear film function. We selected 24 patients, 45 eyes with primary open-angle glaucoma or intraocular hypertension. All of the patients topically used
Takashi Kanamoto et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 31(3), 156-164 (2015-02-25)
To evaluate some clinically important features of benzalkonium chloride (BAK) toxicity by comparing tafluprost with 0.001% BAK and travoprost preserved with SofZia applied to the ocular surface of the eyes with glaucoma. This was a prospective, randomized, observer unmasked, multicenter
Shinsaku Yamane et al.
Investigative ophthalmology & visual science, 56(4), 2547-2552 (2015-03-20)
The purpose of this study was to determine whether a better IOP reduction can be observed in conscious, normotensive monkeys treated with ONO-9054, a novel dual EP3 and FP receptor agonist, compared with prostaglandin F2α analogs. The binding affinities and
Joao F Lopes et al.
BMC ophthalmology, 15, 166-166 (2015-11-14)
Prostaglandin analogs reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; however, these medications may affect the ocular surface and elicit ocular discomfort when preserved with benzalkonium chloride (BAK). This was an open-label, single-arm study conducted in
Katsuyoshi Suzuki et al.
Journal of glaucoma, 24(6), e145-e150 (2013-11-19)
To evaluate the safety and efficacy of benzalkonium chloride (BAK)-optimized tafluprost (with a BAK concentration reduced from 0.01% to 0.001%) in glaucoma patients with existing superficial punctate keratitis (SPK). A prospective, multicenter, open-label study was designed to compare BAK-optimized tafluprost
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service